Personalized medicine: A pediatric perspective

被引:0
|
作者
Daniel Arnold
Bridgette L. Jones
机构
[1] University of Missouri-Kansas City,Children’s Mercy Hospital and Clinics Kansas City, Department of Pediatrics, School of Medicine
来源
关键词
Asthma; Atopic Dermatitis; Allergic Rhinitis; Allergy Clin Immunol; Montelukast;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of pediatric personalized medicine is to uniquely combine genetic variation with developmental stage and environmental exposure to provide a tailored preventive, diagnostic, and therapeutic regimen. Recent advances in genomic research have identified many genetic variants that may be related to allergic and inflammatory disease and therapeutic response. These include variants involved in immune response, barrier proteins, and medication response. Current evidence also suggests that the effect of genetic variation often depends on the developmental stage of a child and environmental exposure such as infection or tobacco smoke during a specific stage. Personalized medicine is a new and exciting field with the potential to significantly improve medical care for children and adults.
引用
收藏
页码:426 / 432
页数:6
相关论文
共 50 条
  • [1] Personalized medicine: A pediatric perspective
    Arnold, Daniel
    Jones, Bridgette L.
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2009, 9 (06) : 426 - 432
  • [2] Personalized Medicine and Pediatric Asthma
    Pajor, Nathan M.
    Guilbert, Theresa W.
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2019, 39 (02) : 221 - +
  • [3] A personal perspective on personalized medicine
    Shomron, Noam
    [J]. GENETICS RESEARCH, 2013, 95 (2-3) : 51 - 51
  • [4] Genomics and personalized medicine: a perspective
    Desnick, Robert J.
    [J]. PERSONALIZED MEDICINE, 2009, 6 (02) : 135 - 137
  • [5] Leavitt Provides Perspective on Personalized Medicine
    Boughton, Barbara
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2009, 2 (01): : 3 - 3
  • [6] Perspective: Does personalized medicine hold the future for medicine
    Agyeman, Akosua Adom
    Ofori-Asenso, Richard
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2015, 7 (03): : 239 - 244
  • [7] Personalized medicine for ALL? The pediatric INFORM project
    Worst, B. C.
    van Tilburg, C. M.
    Balasubramanian, G. P.
    Fiesel, P.
    Pfaff, E.
    Pajtler, K.
    Freitag, A.
    Witt, R.
    Kulozik, A. E.
    von Stackelberg, A.
    Meisel, R.
    Borkhardt, A.
    von, Deimling A.
    Eggert, A.
    Lichter, P.
    Capper, D.
    Witt, O.
    Pfister, S. M.
    Jones, D. T. W.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 16 - 17
  • [8] Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine
    Maagdenberg, Hedy
    Vijverberg, Susanne J. H.
    Bierings, Marc B.
    Carleton, Bruce C.
    Arets, Hubertus G. M.
    de Boer, Anthonius
    Maitland-van der Zee, Anke H.
    [J]. PEDIATRIC DRUGS, 2016, 18 (04) : 251 - 260
  • [9] Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine
    Hedy Maagdenberg
    Susanne J. H. Vijverberg
    Marc B. Bierings
    Bruce C. Carleton
    Hubertus G. M. Arets
    Anthonius de Boer
    Anke H. Maitland-van der Zee
    [J]. Pediatric Drugs, 2016, 18 : 251 - 260
  • [10] Royal Society puts personalized medicine in perspective
    Malorye Allison Branca
    [J]. Nature Reviews Drug Discovery, 2005, 4 : 872 - 872